131 related articles for article (PubMed ID: 29883727)
1. Safer anti-inflammatory therapy through dual COX-2/5-LOX inhibitors: A structure-based approach.
P JJ; Manju SL; Ethiraj KR; Elias G
Eur J Pharm Sci; 2018 Aug; 121():356-381. PubMed ID: 29883727
[TBL] [Abstract][Full Text] [Related]
2. Thiazoles and Thiazolidinones as COX/LOX Inhibitors.
Liaras K; Fesatidou M; Geronikaki A
Molecules; 2018 Mar; 23(3):. PubMed ID: 29562646
[TBL] [Abstract][Full Text] [Related]
3. Exploring new imines as anti-inflammatory COX and 5-LOX inhibitors with an improved pharmacokinetic profile.
Said MF; Moussa BA; Mahrouse MA; Marie SM; Mohamed NM
Future Med Chem; 2024 Feb; 16(4):311-334. PubMed ID: 38293746
[No Abstract] [Full Text] [Related]
4. Inhibitors of prostaglandin synthesis inhibit human prostate tumor cell invasiveness and reduce the release of matrix metalloproteinases.
Attiga FA; Fernandez PM; Weeraratna AT; Manyak MJ; Patierno SR
Cancer Res; 2000 Aug; 60(16):4629-37. PubMed ID: 10969817
[TBL] [Abstract][Full Text] [Related]
5. Computational screening of potential anti-inflammatory leads from Jeevaneeya Rasayana plants targeting COX-2 and 5- LOX by molecular docking and dynamic simulation approaches.
Hemavathi KN; Skariyachan S; Raju R; Keshava Prasad TS; Abhinand CS
Comput Biol Med; 2024 Mar; 171():108164. PubMed ID: 38412690
[TBL] [Abstract][Full Text] [Related]
6. Targeting Mammalian 5-Lipoxygenase by Dietary Phenolics as an Anti-Inflammatory Mechanism: A Systematic Review.
Giménez-Bastida JA; González-Sarrías A; Laparra-Llopis JM; Schneider C; Espín JC
Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360703
[TBL] [Abstract][Full Text] [Related]
7. Dual-target inhibitors based on COX-2: a review from medicinal chemistry perspectives.
Zhang F; Zhu G; Li Y; Qi Y; Wang Z; Li W
Future Med Chem; 2023 Dec; 15(23):2209-2233. PubMed ID: 38095081
[TBL] [Abstract][Full Text] [Related]
8. Dual COX-2/5-LOX inhibitors from
Tian YQ; Liu J; Cheng P; Zou J; Xu HF; Shi XH; Zhang YS; Mei L
Front Chem; 2023; 11():1287570. PubMed ID: 38268762
[TBL] [Abstract][Full Text] [Related]
9. Lipoxygenase and Cyclooxygenase Pathways and Colorectal Cancer Prevention.
Rao CV; Janakiram NB; Mohammed A
Curr Colorectal Cancer Rep; 2012 Dec; 8(4):316-324. PubMed ID: 23293573
[TBL] [Abstract][Full Text] [Related]
10. Biological Evaluation of Naproxen-Dehydrodipeptide Conjugates with Self-Hydrogelation Capacity as Dual LOX/COX Inhibitors.
Moreira R; Jervis PJ; Carvalho A; Ferreira PMT; Martins JA; Valentão P; Andrade PB; Perreira DM
Pharmaceutics; 2020 Feb; 12(2):. PubMed ID: 32028608
[TBL] [Abstract][Full Text] [Related]
11. Disease-modifying effects of COX-2 selective inhibitors and non-selective NSAIDs in osteoarthritis: a systematic review.
Nakata K; Hanai T; Take Y; Osada T; Tsuchiya T; Shima D; Fujimoto Y
Osteoarthritis Cartilage; 2018 Oct; 26(10):1263-1273. PubMed ID: 29890262
[TBL] [Abstract][Full Text] [Related]
12. Incidence of Upper and Lower Gastrointestinal Bleeding in New Users of Low-Dose Aspirin.
Cea Soriano L; Lanas A; Soriano-Gabarró M; García Rodríguez LA
Clin Gastroenterol Hepatol; 2019 Apr; 17(5):887-895.e6. PubMed ID: 29908361
[TBL] [Abstract][Full Text] [Related]
13. Inspiromatic-safety and efficacy study of a new generation dry powder inhaler in asthmatic children.
Steuer G; Prais D; Mussaffi H; Mei-Zahav M; Bar-On O; Levine H; Gendler Y; Blau H; Stafler P
Pediatr Pulmonol; 2018 Oct; 53(10):1348-1355. PubMed ID: 29905977
[TBL] [Abstract][Full Text] [Related]
14. ACRIN 6684: Multicenter, phase II assessment of tumor hypoxia in newly diagnosed glioblastoma using magnetic resonance spectroscopy.
Ratai EM; Zhang Z; Fink J; Muzi M; Hanna L; Greco E; Richards T; Kim D; Andronesi OC; Mintz A; Kostakoglu L; Prah M; Ellingson B; Schmainda K; Sorensen G; Barboriak D; Mankoff D; Gerstner ER;
PLoS One; 2018; 13(6):e0198548. PubMed ID: 29902200
[TBL] [Abstract][Full Text] [Related]
15. Identification and development of thiazole leads as COX-2/5-LOX inhibitors through in-vitro and in-vivo biological evaluation for anti-inflammatory activity.
Jacob P J; Manju SL
Bioorg Chem; 2020 Jul; 100():103882. PubMed ID: 32361295
[TBL] [Abstract][Full Text] [Related]
16. Novel class of benzimidazole-thiazole hybrids: The privileged scaffolds of potent anti-inflammatory activity with dual inhibition of cyclooxygenase and 15-lipoxygenase enzymes.
Maghraby MT; Abou-Ghadir OMF; Abdel-Moty SG; Ali AY; Salem OIA
Bioorg Med Chem; 2020 Apr; 28(7):115403. PubMed ID: 32127262
[TBL] [Abstract][Full Text] [Related]
17. Emerging role of 12/15-Lipoxygenase (ALOX15) in human pathologies.
Singh NK; Rao GN
Prog Lipid Res; 2019 Jan; 73():28-45. PubMed ID: 30472260
[TBL] [Abstract][Full Text] [Related]
18. Prostaglandin-cytokine crosstalk in chronic inflammation.
Yao C; Narumiya S
Br J Pharmacol; 2019 Feb; 176(3):337-354. PubMed ID: 30381825
[TBL] [Abstract][Full Text] [Related]
19. Inflammation, a Double-Edge Sword for Cancer and Other Age-Related Diseases.
Gupta SC; Kunnumakkara AB; Aggarwal S; Aggarwal BB
Front Immunol; 2018; 9():2160. PubMed ID: 30319623
[TBL] [Abstract][Full Text] [Related]
20. Synthetically-tailored and nature-derived dual COX-2/5-LOX inhibitors: Structural aspects and SAR.
Meshram MA; Bhise UO; Makhal PN; Kaki VR
Eur J Med Chem; 2021 Dec; 225():113804. PubMed ID: 34479036
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
